Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

Jounce Therapeutics Inc (JNCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2021	06-2021	03-2021	12-2020	09-2020
Assets
Current Assets
Cash & Cash Equivalents	145,365	140,814	196,273	147,493	67,103
Marketable Securities	74,235	79,319	61,205	58,985	37,144
Receivables	N/A	24,976	N/A	N/A	N/A
TOTAL	$229,245	$257,119	$267,013	$211,391	$107,457

Non-Current Assets
PPE Net	5,476	6,026	6,709	7,336	8,097
Investments And Advances	29,438	26,015	13,808	6,710	1,034
Other Non-Current Assets	16,226	17,000	17,623	18,799	19,245
TOTAL	$51,140	$49,041	$38,140	$32,845	$28,376

Total Assets	$280,385	$306,160	$305,153	$244,236	$135,833

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	1,754	2,476	1,631	2,036	2,707
Accrued Expenses	12,714	9,853	7,470	12,044	10,323
Other current liabilities	49	34	54	42	74
TOTAL	$18,097	$15,841	$12,925	$19,324	$16,280

Non-Current Liabilities
Deferred Revenues	N/A	N/A	392	1,931	N/A
Other Non-Current Liabilities	10,921	11,857	12,774	13,618	14,466
TOTAL	$10,921	$11,857	$12,774	$13,618	$14,466

Total Liabilities	$29,018	$27,698	$25,699	$32,942	$30,746

Shareholders' Equity
Shares Outstanding, K	51,244	51,232	51,208	45,394	39,851
Common Shares	51	51	51	42	34
Retained earnings	-211,640	-181,547	-177,536	-151,001	-186,473
Other shareholders' equity	-19	-24	-25	-17	45
TOTAL	$251,367	$278,462	$279,454	$211,294	$105,087

Total Liabilities And Equity	$280,385	$306,160	$305,153	$244,236	$135,833